Question 1

How much would I have if I DCA'd $100/week into MCK for 5 years?

Accepted Answer

Dollar cost averaging $100 per week into MCK for 5 years (261 purchases) would have resulted in a total investment of $26,100 and a current value of $52,930, a return of 103%. Using Enhanced DCA, which concentrates buys during dips, the same $100/week base deployed $12,889 and grew to $21,966 — a 70% return.

Question 2

What is the best DCA strategy for MCK?

Accepted Answer

Backtesting shows Enhanced DCA — which increases buy amounts during market dips and reduces or skips buys when MCK is overextended — underperformed standard weekly DCA by 32% over 5 years. The enhanced strategy achieved a 70% return vs 103% for standard DCA.

Question 3

What would $100/week into MCK be worth after 3 years?

Accepted Answer

Investing $100 per week into MCK for 3 years (157 purchases, $15,700 total) would have grown to $22,999 — a 46% return. Enhanced DCA over the same period returned 43%.

Question 4

Is DCA into MCK worth it?

Accepted Answer

Based on a 5-year backtest, DCA into MCK returned 103% with standard weekly purchases. An intelligent DCA strategy that buys more during dips returned 70% over the same period — a 32% shortfall in return, while deploying a similar or smaller amount of capital.

Question 5

How many shares of MCK would I have after DCA for 5 years?

Accepted Answer

Dollar cost averaging $100/week into MCK for 5 years would result in approximately 56 shares with a standard DCA approach (avg entry $463). Enhanced DCA targeting dips results in 23 shares at an average entry of $551.

Question 6

How does MCK DCA compare to the S&P 500?

Accepted Answer

Enhanced DCA into MCK returned 70% over the past 5 years. The S&P 500 (SPY) returned approximately 53% over the same period. MCK's performance reflects its volatility as a healthcare asset. Enhanced DCA underperformed standard DCA by 32% over this period, showing signal-based timing doesn't always beat regular-interval buying.

Question 7

What is the risk of dollar cost averaging into MCK?

Accepted Answer

Past backtest performance does not guarantee future results. MCK is a healthcare asset whose price can fall as well as rise. While DCA reduces timing risk by spreading purchases over time, losses are still possible if the price declines significantly. Always invest within your risk tolerance and consider your overall portfolio diversification.

Question 8

What is the McKesson Corporation dollar cost averaging strategy?

Accepted Answer

Standard DCA invests a fixed amount ($100/week or $433/month) into MCK at regular intervals. Enhanced DCA improves on this by using RSI (Relative Strength Index) signals to increase buy amounts during market dips (oversold conditions) and reduce or skip purchases when the stock is overextended. Over the 5-year backtest, this timing approach has delivered 32% lower returns than standard DCA while deploying less total capital into MCK.

Period	Standard DCA	Enhanced DCA	Alpha
1-Year	12%	18%	+6%
3-Year	46%	43%	-3%
5-Year	103%	70%	-32%

MCK DCA Backtest — Dollar Cost Averaging Results

MCK DCA Results: Key Findings

Alpha you missed while unsubscribed

Dollar cost averaging into MCK — backtest results

Buying the dips for McKesson Corporation